Establishing the Kidney dIsease in the National guarD (KIND) registry: an opportunity for epidemiological and clinical research in Saudi Arabia.
Chronic kidney disease
Kidney disease
Renal registry
Renal transplant
Saudi Arabia
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
19 Feb 2024
19 Feb 2024
Historique:
received:
11
10
2023
accepted:
23
01
2024
medline:
20
2
2024
pubmed:
20
2
2024
entrez:
19
2
2024
Statut:
epublish
Résumé
In Saudi Arabia (SA), there has been an alarming increase in the prevalence of chronic kidney diseases (CKD) over the last three decades. Despite being one of the largest countries in the Middle East, renal conditions remain understudied, and there is limited data on their epidemiology and outcomes in SA. To document the experience of establishing a local renal registry assessing the epidemiology of CKD and identifying potential areas for improving the quality and delivery of care for CKD patients. This is a multi-center retrospective registry. Potential participants were identified through the ICD-10 codes from five hospitals serving the National Guard affiliates in SA. Patients aged ≥ 18 years treated in any National Guard hospital since 2010 for glomerulonephritis, CKD, or received hemodialysis, peritoneal dialysis, or renal transplant were enrolled. Once enrolled in the registry, patients were followed to the last visit date. RedCap was used to create and host the online registry platform. A total of 2,912 patients were included, and more than half were younger than 60 years old. Two-thirds of the patients were overweight (25%) or obese (37%). Glomerulonephritis was diagnosed in 10% of the patients, and dialysis-dependent and kidney transplant patients accounted for 31.4% and 24.4%, respectively. Hypertension and diabetes mellitus were detected among 52% and 43% of the participants, respectively. Hemodialysis was the most prevalent dialysis method, with patients spending 3.6 ± 0.4 h per session to receive this treatment. One in every five participants had a kidney biopsy taken (21%). Several barriers and facilitators of the success of this registry were identified. The KIND registry provides much-needed information about CKD in Saudi Arabia and serves as a model for future projects investigating the natural history and progression of the spectrum of renal diseases. Logistic and financial challenges to the sustainability of registries are identified and discussed.
Sections du résumé
BACKGROUND
BACKGROUND
In Saudi Arabia (SA), there has been an alarming increase in the prevalence of chronic kidney diseases (CKD) over the last three decades. Despite being one of the largest countries in the Middle East, renal conditions remain understudied, and there is limited data on their epidemiology and outcomes in SA.
OBJECTIVES
OBJECTIVE
To document the experience of establishing a local renal registry assessing the epidemiology of CKD and identifying potential areas for improving the quality and delivery of care for CKD patients.
METHODS
METHODS
This is a multi-center retrospective registry. Potential participants were identified through the ICD-10 codes from five hospitals serving the National Guard affiliates in SA. Patients aged ≥ 18 years treated in any National Guard hospital since 2010 for glomerulonephritis, CKD, or received hemodialysis, peritoneal dialysis, or renal transplant were enrolled. Once enrolled in the registry, patients were followed to the last visit date. RedCap was used to create and host the online registry platform.
RESULTS
RESULTS
A total of 2,912 patients were included, and more than half were younger than 60 years old. Two-thirds of the patients were overweight (25%) or obese (37%). Glomerulonephritis was diagnosed in 10% of the patients, and dialysis-dependent and kidney transplant patients accounted for 31.4% and 24.4%, respectively. Hypertension and diabetes mellitus were detected among 52% and 43% of the participants, respectively. Hemodialysis was the most prevalent dialysis method, with patients spending 3.6 ± 0.4 h per session to receive this treatment. One in every five participants had a kidney biopsy taken (21%). Several barriers and facilitators of the success of this registry were identified.
CONCLUSIONS
CONCLUSIONS
The KIND registry provides much-needed information about CKD in Saudi Arabia and serves as a model for future projects investigating the natural history and progression of the spectrum of renal diseases. Logistic and financial challenges to the sustainability of registries are identified and discussed.
Identifiants
pubmed: 38374104
doi: 10.1186/s12882-024-03479-0
pii: 10.1186/s12882-024-03479-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
59Informations de copyright
© 2024. The Author(s).
Références
Gaitonde DY, Cook DL, Rivera IM. Chronic kidney disease: detection and evaluation. Am Fam Physician. 2017;96(12):776–83.
pubmed: 29431364
Ammirati AL. Chronic Kidney Disease. Rev Assoc Med Bras (1992). 2020;66Suppl 1(Suppl 1):s03–9.
doi: 10.1590/1806-9282.66.s1.3
pubmed: 31939529
Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15.
doi: 10.1007/978-981-13-8871-2_1
pubmed: 31399958
Chronic Kidney Disease Prognosis Consortium; Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81. Epub 2010 May 17.
Molaoa TT, Bisiwe FB, Ndlovu KC. End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study. BMC Nephrol. 2021;22(1):174.
doi: 10.1186/s12882-021-02387-x
pubmed: 33975539
pmcid: 8112033
Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020;16(10):573–85 (Epub 2020 Jul 30).
doi: 10.1038/s41581-020-0315-4
pubmed: 32733095
pmcid: 7391926
White Y, Fitzpatrick G. Dialysis: prolonging life or prolonging dying? Ethical, legal and professional considerations for end of life decision making. EDTNA ERCA J. 2006;32(2):99–103.
Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98–107 (Epub 2021 Mar 22).
doi: 10.1159/000514550
pubmed: 33752206
Mittal SK, Ahern L, Flaster E, Maesaka JK, Fishbane S. Self-assessed physical and mental function of haemodialysis patients. Nephrol Dial Transplant. 2001;16(7):1387–94.
doi: 10.1093/ndt/16.7.1387
pubmed: 11427630
Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82–99.
doi: 10.1053/j.ackd.2006.10.001
pubmed: 17200048
Gliklich RE, Dreyer NA, Leavy MB, editors. Registries for Evaluating Patient Outcomes: A User's Guide [Internet]. 3rd ed. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 13(14)-EHC111.
Breckenridge K, Bekker HL, Gibbons E, van der Veer SN, Abbott D, Briançon S, et al. How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting. Nephrol Dial Transplant. 2015;30(10):1605–14 (Epub 2015 May 16).
doi: 10.1093/ndt/gfv209
pubmed: 25982327
pmcid: 4569391
Hinojosa JA, Pandya AG. The Importance of Patient Registries in Skin of Color. J Investig Dermatol Symp Proc. 2017;18(2):S31–3.
doi: 10.1016/j.jisp.2017.01.002
pubmed: 28941490
Will EJ. A short cultural history of the UK renal registry 1995–2020. BMC Nephrology. 2020;21(1).
Danzig MR, Chang P, Wagner AA, Allaf ME, McKiernan JM, Pierorazio PM. Active surveillance for small renal masses: a review of the aims and preliminary results of the DISSRM Registry. Curr Urol Rep. 2016;17(1):4.
doi: 10.1007/s11934-015-0564-0
pubmed: 26711846
Xu H, Lindholm B, Lundström UH, Heimbürger O, Stendahl M, Rydell H, et al. Treatment practices and outcomes in incident peritoneal dialysis patients: the Swedish Renal Registry 2006–2015. Clin Kidney J. 2021;14(12):2539–47.
doi: 10.1093/ckj/sfab130
pubmed: 34950465
pmcid: 8690080
Burke JP, Aljishi M, Francis L, Hoy W, Divi D, Cherian R, et al. Protocol and establishment of a Queensland renal biopsy registry in Australia. BMC Nephrol. 2020;21(1):320.
doi: 10.1186/s12882-020-01983-7
pubmed: 32738876
pmcid: 7395341
Ozeki T, Maruyama S, Nagata M, Shimizu A, Sugiyama H, Sato H, et al. Committee for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology. The revised version 2018 of the nationwide web-based registry system for kidney diseases in Japan: Japan Renal Biopsy Registry and Japan Kidney Disease Registry. Clin Exp Nephrol. 2020;24(11):1058–68 Epub 2020 Aug 6.
doi: 10.1007/s10157-020-01932-6
pubmed: 32761468
pmcid: 7524691
Martín Escobar E; Registro Español de Enfermos Renales (REER). The Spanish Renal Registry: 2013 report and evolution from 2007–2013. Nefrologia. 2016;36(2):97–120. English, Spanish. Epub 2016 Feb 16.
Sophia Wong, Catalin Taraboanta, Gordon Francis, Andrew Ignaszewski, Jiri Frohlich. The British Columbia Familial Hypercholesterolemia Registry. BCMJ,2013;55(7):326–330 - Clinical Articles.
Evans KM, Pyart R, Steenkamp R, Caskey FJ. The UK Renal Registry: making patient data matter. Br J Hosp Med (Lond). 2018;79(5):246–8.
doi: 10.12968/hmed.2018.79.5.246
pubmed: 29727240
Al Attar B. Renal Replacement Therapy in the Kingdom of Saudi Arabia. Saudi J Kidney Dis Transpl. 2021;32(4):1188–1200.
Abouchacra S, Obaidli A, Al-Ghamdi SM, et al. Gulf Cooperation Council-dialysis outcomes and practice patterns study: An overview of anemia management trends at the regional and country specific levels in the Gulf Cooperation Council countries. Saudi J Kidney Dis Transpl. 2016;27(6 Suppl 1):51–61. https://doi.org/10.4103/1319-2442.194895 .
doi: 10.4103/1319-2442.194895
pubmed: 27991479
Huraib S, Al Khader A, Shaheen FA, Abu Aisha H, Souqiyyeh MZ, Al Mohana F, et al. The spectrum of glomerulonephritis in saudi arabia: the results of the saudi registry. Saudi J Kidney Dis Transpl. 2000;11(3):434–41.
Tawhari M, Alhamadh MS, Alhabeeb A, Almutlaq M, Radwi M. Renal transplant experience in a tertiary care center in Saudi Arabia: a retrospective cohort study. Cureus. 2022;14(3): e23019.
pubmed: 35281582
pmcid: 8908280
El Minshawy O, Ghabrah T, El Bassuoni E. End-stage renal disease in Tabuk Area, Saudi Arabia: an epidemiological study. Saudi J Kidney Dis Transpl. 2014;25(1):192–5.
doi: 10.4103/1319-2442.124574
pubmed: 24434411
Oudah N, Al Duhailib Z, Alsaad K, Qurashi S, Ghamdi G, Flaiw A, et al. Glomerulonephritis with crescents among adult Saudi patients outcome and its predictors. Clin Exp Med. 2012;12(2):121–5 (Epub 2011 Jun 26).
doi: 10.1007/s10238-011-0147-4
pubmed: 21706346
United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2022.
Al-Sayyari AA, Shaheen FA. End stage chronic kidney disease in Saudi Arabia. A rapidly changing scene. Saudi Med J. 2011;32(4):339–46.
Wang M, Wang Z, Chen Y, Dong Y. Kidney damage caused by obesity and its feasible treatment drugs. Int J Mol Sci. 2022;23(2):747.
doi: 10.3390/ijms23020747
pubmed: 35054932
pmcid: 8775419
Bonani M, Seeger H, Weber N, Lorenzen JM, Wüthrich RP, Kistler AD. Safety of kidney biopsy when performed as an outpatient procedure. Kidney Blood Press Res. 2021;46(3):310–22 (Epub 2021 Jun 2).
doi: 10.1159/000515439
pubmed: 34077930
Emelianova D, Prikis M, Morris CS, Gibson PC, Solomon R, Scriver G, et al. The evolution of performing a kidney biopsy: a single center experience comparing native and transplant kidney biopsies performed by interventional radiologists and nephrologists. BMC Nephrol. 2022;23(1):226.
doi: 10.1186/s12882-022-02860-1
pubmed: 35752759
pmcid: 9233823
Aaltonen S, Finne P, Honkanen E. Outpatient kidney biopsy: a single center experience and review of literature. Nephron. 2020;144(1):14–20 (Epub 2019 Oct 2).
doi: 10.1159/000503255
pubmed: 31578024
Almutairi FM, Al-Duais MA, Shalaby KA, Sakran MI. Analysis of patients with end-stage renal disease on dialysis in Tabuk City, Saudi Arabia: A single-center, three-year retrospective study. Saudi J Kidney Dis Transpl. 2017;28(2):349–54.
doi: 10.4103/1319-2442.202769
pubmed: 28352019
Althumiri NA, Basyouni MH, AlMousa N, AlJuwaysim MF, Almubark RA, BinDhim NF, et al. Obesity in Saudi Arabia in 2020: prevalence, distribution, and its current association with various health conditions. Healthcare (Basel). 2021;9(3):311.
doi: 10.3390/healthcare9030311
pubmed: 33799725
ANZDATA 46th Annual Report 2023 (data to 2022). ANZDATA 46th Annual Report 2023 . November 23, 2023. Accessed 21 Dec 2023. https://www.anzdata.org.au/report/anzdata-46th-annual-report-2023-data-to-2022/ .
Venuthurupalli SK, Healy H, Fassett R, Cameron A, Wang Z, Hoy WE. Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report. Nephrology (Carlton). 2019;24(12):1257–64. https://doi.org/10.1111/nep.13567 .
doi: 10.1111/nep.13567
pubmed: 30663166
Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG. CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia. BMC Nephrol. 2017;18(1):189. Published 2017 Jun 7. https://doi.org/10.1186/s12882-017-0607-5 .